Skip to main content
. 2017 Jun 30;13(3):227–233. doi: 10.3988/jcn.2017.13.3.227

Table 3. Neurological manifestations and laboratory findings in patients with laboratory-confirmed MERS.

Patient 1 Patient 2 Patient 3 Patient 4
Neurological symptoms Hypersomnolence and weakness in all four limbs Tingling/pain in both hands and below the knees, and weakness in both legs Tingling in distal parts of both hands and feet Tingling in both hands
Days after MERS onset Unclear* 16 20 21
Neurological examination
 Cranial nerves Ptosis and ophthalmoplegia Normal Normal Normal
 Motor Weakness in all four limbs Proximal dominant weakness in both legs Normal Normal
 Sensory Normal Normal Hypesthesia in distal parts of all four limbs Normal
 Deep tendon reflex Hyporeflexia in all four limbs Hyporeflexia in both legs Hyporeflexia in both legs Normal
 Cerebellar function Limb ataxia Normal Normal Normal
Laboratory findings
 CSF Normal NA NA NA
 NCS Normal Normal Normal NA
 Peak serum creatine kinase, U/L 45 48 99 NA

*Neurological symptoms were detected 24 days after the initial onset of respiratory symptoms.

CSF: cerebrospinal fluid, MERS: Middle East respiratory syndrome, NA: not available, NCS: nerve conduction study.